When your manuscript is accepted for publication you will receive notification from the editor in the form of a final "Accept" decision letter. Once you receive this acceptance, we ask that you follow the directions below to ensure timely publication of your manuscript. Please do not send us these materials until your manuscript is formally and fully accepted.
Once your manuscript is accepted we need 4 items from you before production can begin. Do NOT resubmit these materials to our ScholarOne submissionsite. Instead, PLEASE SEND THESE MATERIALS to cdev@srcd.org:
-
Final Manuscript
Please ensure it conforms to the Publication Checklist requirements (failure to do so may lead to the manuscript being returned to you for correction, and could delay publication.) -
A Public Summary
Written in accessible language for a lay audience. Please see the Public Summary Instructions and Examples for more information. -
Copyright Transfer Agreement (CTA) -- Formerly "Exclusive Licensing Form (ELF)"
All authors listed on the manuscript must submit a signed CTA. Digital/electronic signatures are not permitted—a physical signature is required. -
Full Disclosure of Interests Form (FDI)
All authors listed on the manuscript must submit a FDI
Optional: Color Figures
Color figures publish online for free, but if you would like your figures printed in color there is a fee. Please complete and return the Color Charge Form.
Important Embargo Information for authors
Note to NIH Grantees
Pursuant to NIH mandate, Society through Wiley-Blackwell will post the accepted version of Contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.